Squarepoint
BIVI icon

Squarepoint’s BioVie BIVI Stock Holding History

Squarepoint’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,172
Closed -$16.4K – 4288
2025
Q4 		$16.4K Sell
14,172
-19,122
-57% -$30.8K ﹤0.01% 4176
2025
Q3 		$63.3K Buy
+33,294
New +$135K ﹤0.01% 4190
2025
Q1 		– Sell
-1,421
Closed -$28.4K – 4603
2024
Q4 		$28.4K Buy
+1,421
New +$34.3K ﹤0.01% 4909
2023
Q2 		– Sell
-259
Closed -$209K – 3578
2023
Q1 		$209K Buy
+259
New +$172K ﹤0.01% 2781

Other funds holding BIVI

DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Squarepoint's BIVI Position: Q1 2026 in Review

Squarepoint sold out of BioVie (BIVI) in Q1 2026, closing a stake of 14,172 shares — an estimated $16.4K sold.

Squarepoint first reported a position in BIVI in Q1 2023 and held it in 4 quarters. The position peaked at $209K in Q1 2023. 33 funds tracked by Wall St. Rank hold BIVI as of Q1 2026.

  • Squarepoint reported no remaining BioVie position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 14,172 BioVie shares in Q1 2026, an estimated $16.4K.
  • Squarepoint first reported a position in BioVie in Q1 2023 and held it in 4 quarters.
  • Squarepoint's BioVie position peaked at $209K in Q1 2023.
  • 33 funds tracked by Wall St. Rank held BioVie as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.